A Zebrafish Genetic Screen Identifies Neuromedin U as a Regulator of Sleep/Wake States

Neuron

Volumn 89, Issue 4, 2016, Pages 842-856

  Chiu, Cindy N ^a,e   Rihel, Jason ^b,c,e   Lee, Daniel A ^a   Singh, Chanpreet ^a   Mosser, Eric A ^a,e   Chen, Shijia ^a   Sapin, Viveca ^a   Pham, Uyen ^a   Engle, Jae ^a   Niles, Brett J ^a   Montz, Christin J ^a   Chakravarthy, Sridhara ^a   Zimmerman, Steven ^c   Salehi Ashtiani, Kourosh ^d,f   Vidal, Marc ^d   Schier, Alexander F ^c,d   Prober, David A ^a  

^a California Institute of Technology   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c HARVARD UNIVERSITY   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f NEW YORK UNIVERSITY ABU DHABI   (United Arab Emirates)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; NEUROMEDIN U; NEUROMEDIN U RECEPTOR; NEUROPEPTIDE RECEPTOR; UNCLASSIFIED DRUG; 2-METHYL-4-(N-PROPYL-N-CYCLOPROANEMETHYLAMINO)-5-CHLORO-6-(2,4,6-TRICHLORANILINO)PYRIMIDINE; ANILINE DERIVATIVE; COMPLEMENT COMPONENT C3B RECEPTOR; NEUROPEPTIDE; NEUROTRANSMITTER RECEPTOR; PYRIMIDINE DERIVATIVE; ZEBRAFISH PROTEIN;

ANIMAL BEHAVIOR; ANIMAL TISSUE; AROUSAL; ARTICLE; BRAIN STEM; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENETIC SCREENING; HYPERACTIVITY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LARVA; NEUROANATOMY; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SLEEP; SLEEP WAKING CYCLE; SURVIVAL RATE; WAKEFULNESS; ZEBRA FISH; AGE; ANIMAL; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; MOTOR ACTIVITY; NERVE CELL; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

AGE FACTORS; ANILINE COMPOUNDS; ANIMALS; BRAIN STEM; GENE EXPRESSION REGULATION; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LARVA; MICE, TRANSGENIC; MOTOR ACTIVITY; NEURONS; NEUROPEPTIDES; PITUITARY-ADRENAL SYSTEM; PYRIMIDINES; RECEPTORS, COMPLEMENT 3B; RECEPTORS, NEUROTRANSMITTER; SIGNAL TRANSDUCTION; SLEEP; WAKEFULNESS; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 84958212456     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2016.01.007     Document Type: Article

References (57)

1. Ahnaou A., Drinkenburg W.H. Neuromedin U(2) receptor signaling mediates alteration of sleep-wake architecture in rats. Neuropeptides 2011, 45:165-174.
2. Allada R., Siegel J.M. Unearthing the phylogenetic roots of sleep. Curr. Biol. 2008, 18:R670-R679.
3. Alsop D., Vijayan M.M. Development of the corticosteroid stress axis and receptor expression in zebrafish. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008, 294:R711-R719.
4. Asakawa K., Kawakami K. The Tol2-mediated Gal4-UAS method for gene and enhancer trapping in zebrafish. Methods 2009, 49:275-281.
5. Austin C., Oka M., Nandha K.A., Legon S., Khandan-Nia N., Lo G., Bloom S.R. Distribution and developmental pattern of neuromedin U expression in the rat gastrointestinal tract. J. Mol. Endocrinol. 1994, 12:257-263.
6. Berridge C.W., Waterhouse B.D. The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res. Brain Res. Rev. 2003, 42:33-84.
7. Brighton P.J., Szekeres P.G., Willars G.B. Neuromedin U and its receptors: structure, function, and physiological roles. Pharmacol. Rev. 2004, 56:231-248.
8. Cahill G.M., Hurd M.W., Batchelor M.M. Circadian rhythmicity in the locomotor activity of larval zebrafish. Neuroreport 1998, 9:3445-3449.
9. Chang F.C., Opp M.R. Role of corticotropin-releasing hormone in stressor-induced alterations of sleep in rat. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002, 283:R400-R407.
10. Chiu C.N., Prober D.A. Regulation of zebrafish sleep and arousal states: current and prospective approaches. Front. Neural Circuits 2013, 7:58.
11. Cirelli C., Bushey D., Hill S., Huber R., Kreber R., Ganetzky B., Tononi G. Reduced sleep in Drosophila Shaker mutants. Nature 2005, 434:1087-1092.
12. De Marco R.J., Groneberg A.H., Yeh C.M., Castillo Ramírez L.A., Ryu S. Optogenetic elevation of endogenous glucocorticoid level in larval zebrafish. Front. Neural Circuits 2013, 7:82.
13. Driever W., Solnica-Krezel L., Schier A.F., Neuhauss S.C., Malicki J., Stemple D.L., Stainier D.Y., Zwartkruis F., Abdelilah S., Rangini Z., et al. A genetic screen for mutations affecting embryogenesis in zebrafish. Development 1996, 123:37-46.
14. Eaves M., Thatcher-Britton K., Rivier J., Vale W., Koob G.F. Effects of corticotropin releasing factor on locomotor activity in hypophysectomized rats. Peptides 1985, 6:923-926.
15. Elbaz I., Yelin-Bekerman L., Nicenboim J., Vatine G., Appelbaum L. Genetic ablation of hypocretin neurons alters behavioral state transitions in zebrafish. J. Neurosci. 2012, 32:12961-12972.
16. Fujii R., Hosoya M., Fukusumi S., Kawamata Y., Habata Y., Hinuma S., Onda H., Nishimura O., Fujino M. Identification of neuromedin U as the cognate ligand of the orphan G protein-coupled receptor FM-3. J. Biol. Chem. 2000, 275:21068-21074.
17. Gartlon J., Szekeres P., Pullen M., Sarau H.M., Aiyar N., Shabon U., Michalovich D., Steplewski K., Ellis C., Elshourbagy N., et al. Localisation of NMU1R and NMU2R in human and rat central nervous system and effects of neuromedin-following central administration in rats. Psychopharmacology (Berl.) 2004, 177:1-14.
18. Graham E.S., Turnbull Y., Fotheringham P., Nilaweera K., Mercer J.G., Morgan P.J., Barrett P. Neuromedin U and Neuromedin U receptor-expression in the mouse and rat hypothalamus: effects of nutritional status. J. Neurochem. 2003, 87:1165-1173.
19. Haffter P., Granato M., Brand M., Mullins M.C., Hammerschmidt M., Kane D.A., Odenthal J., van Eeden F.J., Jiang Y.J., Heisenberg C.P., et al. The identification of genes with unique and essential functions in the development of the zebrafish, Danio rerio. Development 1996, 123:1-36.
20. Hanada R., Nakazato M., Murakami N., Sakihara S., Yoshimatsu H., Toshinai K., Hanada T., Suda T., Kangawa K., Matsukura S., Sakata T. A role for neuromedin U in stress response. Biochem. Biophys. Res. Commun. 2001, 289:225-228.
21. Hanada T., Date Y., Shimbara T., Sakihara S., Murakami N., Hayashi Y., Kanai Y., Suda T., Kangawa K., Nakazato M. Central actions of neuromedin U via corticotropin-releasing hormone. Biochem. Biophys. Res. Commun. 2003, 311:954-958.
22. Hanada R., Teranishi H., Pearson J.T., Kurokawa M., Hosoda H., Fukushima N., Fukue Y., Serino R., Fujihara H., Ueta Y., et al. Neuromedin U has a novel anorexigenic effect independent of the leptin signaling pathway. Nat. Med. 2004, 10:1067-1073.
23. Hashimoto T., Masui H., Uchida Y., Sakura N., Okimura K. Agonistic and antagonistic activities of neuromedin U-analogs substituted with glycine or D-amino acid on contractile activity of chicken crop smooth muscle preparations. Chem. Pharm. Bull. (Tokyo) 1991, 39:2319-2322.
24. Herget U., Wolf A., Wullimann M.F., Ryu S. Molecular neuroanatomy and chemoarchitecture of the neurosecretory preoptic-hypothalamic area in zebrafish larvae. J. Comp. Neurol. 2014, 522:1542-1564.
25. Howard A.D., Wang R., Pong S.S., Mellin T.N., Strack A., Guan X.M., Zeng Z., Williams D.L., Feighner S.D., Nunes C.N., et al. Identification of receptors for neuromedin U and its role in feeding. Nature 2000, 406:70-74.
26. Huang Z.L., Urade Y., Hayaishi O. Prostaglandins and adenosine in the regulation of sleep and wakefulness. Curr. Opin. Pharmacol. 2007, 7:33-38.
27. Hunsley M.S., Palmiter R.D. Norepinephrine-deficient mice exhibit normal sleep-wake states but have shorter sleep latency after mild stress and low doses of amphetamine. Sleep 2003, 26:521-526.
28. Ivanov T.R., Lawrence C.B., Stanley P.J., Luckman S.M. Evaluation of neuromedin U actions in energy homeostasis and pituitary function. Endocrinology 2002, 143:3813-3821.
29. Jedema H.P., Grace A.A. Corticotropin-releasing hormone directly activates noradrenergic neurons of the locus ceruleus recorded in vitro. J. Neurosci. 2004, 24:9703-9713.
30. Koh K., Joiner W.J., Wu M.N., Yue Z., Smith C.J., Sehgal A. Identification of SLEEPLESS, a sleep-promoting factor. Science 2008, 321:372-376.
31. Koob G.F., Heinrichs S.C. A role for corticotropin releasing factor and urocortin in behavioral responses to stressors. Brain Res. 1999, 848:141-152.
32. Kurosawa K., Sakura N., Hashimoto T. Structure-activity relationships of neuromedin U. III. Contribution of two phenylalanine residues in dog neuromedin U-to the contractile activity. Chem. Pharm. Bull. (Tokyo) 1996, 44:1880-1884.
33. Lee I.T., Chang A.S., Manandhar M., Shan Y., Fan J., Izumo M., Ikeda Y., Motoike T., Dixon S., Seinfeld J.E., et al. Neuromedin s-producing neurons act as essential pacemakers in the suprachiasmatic nucleus to couple clock neurons and dictate circadian rhythms. Neuron 2015, 85:1086-1102.
34. Malendowicz L.K., Ziolkowska A., Rucinski M. Neuromedins U and S involvement in the regulation of the hypothalamo-pituitary-adrenal axis. Front. Endocrinol. (Lausanne) 2012, 3:156.
35. Morin S.M., Ling N., Liu X.J., Kahl S.D., Gehlert D.R. Differential distribution of urocortin- and corticotropin-releasing factor-like immunoreactivities in the rat brain. Neuroscience 1999, 92:281-291.
36. Nakazato M., Hanada R., Murakami N., Date Y., Mondal M.S., Kojima M., Yoshimatsu H., Kangawa K., Matsukura S. Central effects of neuromedin U in the regulation of energy homeostasis. Biochem. Biophys. Res. Commun. 2000, 277:191-194.
37. Nogueiras R., Tovar S., Mitchell S.E., Barrett P., Rayner D.V., Dieguez C., Williams L.M. Negative energy balance and leptin regulate neuromedin-expression in the rat pars tuberalis. J. Endocrinol. 2006, 190:545-553.
38. Novak C.M., Zhang M., Levine J.A. Neuromedin U in the paraventricular and arcuate hypothalamic nuclei increases non-exercise activity thermogenesis. J. Neuroendocrinol. 2006, 18:594-601.
39. Novak C.M., Zhang M., Levine J.A. Sensitivity of the hypothalamic paraventricular nucleus to the locomotor-activating effects of neuromedin U in obesity. Brain Res. 2007, 1169:57-68.
40. Opp M.R. Corticotropin-releasing hormone involvement in stressor-induced alterations in sleep and in the regulation of waking. Adv. Neuroimmunol. 1995, 5:127-143.
41. Peier A., Kosinski J., Cox-York K., Qian Y., Desai K., Feng Y., Trivedi P., Hastings N., Marsh D.J. The antiobesity effects of centrally administered neuromedin U and neuromedin S are mediated predominantly by the neuromedin U receptor 2 (NMUR2). Endocrinology 2009, 150:3101-3109.
42. Pfeiffenberger C., Allada R. Cul3 and the BTB adaptor insomniac are key regulators of sleep homeostasis and a dopamine arousal pathway in Drosophila. PLoS Genet. 2012, 8:e1003003.
43. Prober D.A., Rihel J., Onah A.A., Sung R.J., Schier A.F. Hypocretin/orexin overexpression induces an insomnia-like phenotype in zebrafish. J. Neurosci. 2006, 26:13400-13410.
44. Rogulja D., Young M.W. Control of sleep by cyclin A and its regulator. Science 2012, 335:1617-1621.
45. Sakura N., Ohta S., Uchida Y., Kurosawa K., Okimura K., Hashimoto T. Structure-activity relationships of rat neuromedin U for smooth muscle contraction. Chem. Pharm. Bull. (Tokyo) 1991, 39:2016-2020.
46. Sakura N., Kurosawa K., Hashimoto T. Structure-activity relationships of neuromedin U. IV. Absolute requirement of the arginine residue at position 7 of dog neuromedin U-for contractile activity. Chem. Pharm. Bull. (Tokyo) 2000, 48:1166-1170.
47. Semjonous N.M., Smith K.L., Parkinson J.R., Gunner D.J., Liu Y.L., Murphy K.G., Ghatei M.A., Bloom S.R., Small C.J. Coordinated changes in energy intake and expenditure following hypothalamic administration of neuropeptides involved in energy balance. Int. J. Obes. 2009, 33:775-785.
48. Stavropoulos N., Young M.W. insomniac and Cullin-regulate sleep and wakefulness in Drosophila. Neuron 2011, 72:964-976.
49. Szekeres P.G., Muir A.I., Spinage L.D., Miller J.E., Butler S.I., Smith A., Rennie G.I., Murdock P.R., Fitzgerald L.R., Wu Hl., et al. Neuromedin U is a potent agonist at the orphan G protein-coupled receptor FM3. J. Biol. Chem. 2000, 275:20247-20250.
50. Thakkar M.M. Histamine in the regulation of wakefulness. Sleep Med. Rev. 2011, 15:65-74.
51. Wendelaar Bonga S.E. The stress response in fish. Physiol. Rev. 1997, 77:591-625.
52. Woods I.G., Schoppik D., Shi V.J., Zimmerman S., Coleman H.A., Greenwood J., Soucy E.R., Schier A.F. Neuropeptidergic signaling partitions arousal behaviors in zebrafish. J. Neurosci. 2014, 34:3142-3160.
53. Wren A.M., Small C.J., Abbott C.R., Jethwa P.H., Kennedy A.R., Murphy K.G., Stanley S.A., Zollner A.N., Ghatei M.A., Bloom S.R. Hypothalamic actions of neuromedin U. Endocrinology 2002, 143:4227-4234.
54. Zeng H., Gragerov A., Hohmann J.G., Pavlova M.N., Schimpf B.A., Xu H., Wu L.J., Toyoda H., Zhao M.G., Rohde A.D., et al. Neuromedin U receptor 2-deficient mice display differential responses in sensory perception, stress, and feeding. Mol. Cell. Biol. 2006, 26:9352-9363.
55. Zhdanova I.V. Sleep and its regulation in zebrafish. Rev. Neurosci. 2011, 22:27-36.
56. Zhdanova I.V., Wang S.Y., Leclair O.U., Danilova N.P. Melatonin promotes sleep-like state in zebrafish. Brain Res. 2001, 903:263-268.
57. Ziv L., Muto A., Schoonheim P.J., Meijsing S.H., Strasser D., Ingraham H.A., Schaaf M.J., Yamamoto K.R., Baier H. An affective disorder in zebrafish with mutation of the glucocorticoid receptor. Mol. Psychiatry 2013, 18:681-691.